Intel Corp (INTC) ($21.48): Has a buy rating according to ValuEngine with a favorable P/E. The stock is well below its 200-day SMA at $26.07. Intel declined from a multi-year high at $29.27 on May 3 to a year to date low at 21.40 on Oct 12. The weekly chart is negative but oversold with the stock closing in on its 200-week SMA at $21.14, which is my semiannual value level. Intel has warned on earnings and thus the bar is set much lower. Intel is in my ValuTrader Model Portfolio and subscribers will be adding to this position on a GTC limit order to buy weakness to $21.14.
Johnson & Johnson (JNJ) ($67.97): Has a buy rating according to ValuEngine with a reasonable P/E and is above its 200-day SMA at $66.08. The stock set a multi-year high at $69.75 on Aug. 1. JNJ turned negative on its weekly chart at Friday's close with the 200-week SMA at $62.12. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.
Coca Cola (KO) ($38.23): Has a buy rating according to ValuEngine with an elevated P/E and is above its 200-day SMA at $37.02. The stock set its 2012 high at $40.66 on July 31 after a 2012 low at $33.28 on Jan. 13. The weekly chart turned negative at Friday's close with the 200-week SMA at $30.33. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.
UnitedHealth Group (UNH) ($57.07): Has a strong buy rating according to ValuEngine with a reasonable P/E and is above its 200-day SMA at $55.19. UNH set a multi-year high at $60.75 on June 19 then a second half 2012 low at $50.32 on Aug. 2. The stock has a positive weekly chart profile with the 200-week SMA is $39.28. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.At the time of publication the author held no positions in any of the stocks mentioned. Follow @Suttmeier This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV